Commonwealth Equity Services
DARE icon

Commonwealth Equity Services’s Dare Bioscience DARE Stock Holding History

Commonwealth Equity Services’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,735
Closed -$40K – 4279
2025
Q2 		$40K Buy
16,735
+50
+0.3% +$146 ﹤0.01% 4177
2025
Q1 		$48K Buy
16,685
+50
+0.3% +$155 ﹤0.01% 4066
2024
Q4 		$52K Sell
16,635
-851
-5% -$2.95K ﹤0.01% 3980
2024
Q3 		$57K Buy
17,486
+13,659
+357% +$46.7K ﹤0.01% 3920
2024
Q2 		$15K Hold
3,827
– – ﹤0.01% 3980
2024
Q1 		$23K Buy
3,827
+1,108
+41% +$5.43K ﹤0.01% 3951
2023
Q4 		$10K Sell
2,719
-1,392
-34% -$6.36K ﹤0.01% 3858
2023
Q3 		$23K Sell
4,111
-21
-0.5% -$173 ﹤0.01% 3723
2023
Q2 		$45K Sell
4,132
-250
-6% -$2.97K ﹤0.01% 3671
2023
Q1 		$54 Buy
4,382
+750
+21% +$9.96K ﹤0.01% 3572
2022
Q4 		$36K Hold
3,632
– – ﹤0.01% 3542
2022
Q3 		$43K Hold
3,632
– – ﹤0.01% 3502
2022
Q2 		$53K Buy
3,632
+1,330
+58% +$20K ﹤0.01% 3475
2022
Q1 		$41K Sell
2,302
-313
-12% -$5.92K ﹤0.01% 3602
2021
Q4 		$62K Buy
2,615
+459
+21% +$9.44K ﹤0.01% 3510
2021
Q3 		$43K Hold
2,156
– – ﹤0.01% 3507
2021
Q2 		$48K Buy
2,156
+771
+56% +$13.2K ﹤0.01% 3464
2021
Q1 		$28K Buy
+1,385
New +$33.8K ﹤0.01% 3365
2016
Q4 		– Sell
-131
Closed -$16K – 2326
2016
Q3 		$16K Hold
131
– – ﹤0.01% 2226
2016
Q2 		$33K Sell
131
-42
-24% -$13.4K ﹤0.01% 2180
2016
Q1 		$56K Hold
173
– – ﹤0.01% 2118
2015
Q4 		$58K Hold
173
– – ﹤0.01% 2088
2015
Q3 		$76K Buy
+173
New +$87K ﹤0.01% 2014

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $794M AUM 22.68% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commonwealth Equity Services's DARE Position: Q3 2025 in Review

Commonwealth Equity Services sold out of Dare Bioscience (DARE) in Q3 2025, closing a stake of 16,735 shares — an estimated $40K sold.

Commonwealth Equity Services first reported a position in DARE in Q3 2015 and held it in 23 quarters. The position peaked at $76K in Q3 2015. 21 funds tracked by Wall St. Rank hold DARE as of Q3 2025.

  • Commonwealth Equity Services reported no remaining Dare Bioscience position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 16,735 Dare Bioscience shares in Q3 2025, an estimated $40K.
  • Commonwealth Equity Services first reported a position in Dare Bioscience in Q3 2015 and held it in 23 quarters.
  • Commonwealth Equity Services's Dare Bioscience position peaked at $76K in Q3 2015.
  • 21 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.